Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils

Increasing evidence indicates that oligomeric protein assemblies may represent the molecular species responsible for cytotoxicity in a range of neurological disorders including Alzheimer and Parkinson diseases. We use all-atom computer simulations to reveal that the process of oligomerization can be divided into two steps. The first is characterised by a hydrophobic coalescence resulting in the formation of molten oligomers in which hydrophobic residues are sequestered away from the solvent. In the second step, the oligomers undergo a process of reorganisation driven by interchain hydrogen bonding interactions that induce the formation of β sheet rich assemblies in which hydrophobic groups can become exposed. Our results show that the process of aggregation into either ordered or amorphous species is largely determined by a competition between the hydrophobicity of the amino acid sequence and the tendency of polypeptide chains to form arrays of hydrogen bonds. We discuss how the increase in solvent-exposed hydrophobic surface resulting from such a competition offers an explanation for recent observations concerning the cytotoxicity of oligomeric species formed prior to mature amyloid fibrils.

[1]  R. Carrotta,et al.  Conformational characterization of oligomeric intermediates and aggregates in β‐lactoglobulin heat aggregation , 2001, Protein science : a publication of the Protein Society.

[2]  C. Dobson,et al.  Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation. , 2006, Journal of molecular biology.

[3]  Charles M. Lieber,et al.  Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. , 1997, Chemistry & biology.

[4]  Roger D Kamm,et al.  Kinetic control of dimer structure formation in amyloid fibrillogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Lansbury,et al.  A century-old debate on protein aggregation and neurodegeneration enters the clinic , 2006, Nature.

[6]  S. Santini,et al.  In Silico Assembly of Alzheimer's Aβ16-22 Peptide into β-Sheets , 2004 .

[7]  G. Melacini,et al.  Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. , 2007, Journal of the American Chemical Society.

[8]  C. Dobson,et al.  Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. , 2005, Journal of molecular biology.

[9]  E. Shakhnovich,et al.  The folding thermodynamics and kinetics of crambin using an all-atom Monte Carlo simulation. , 2000, Journal of molecular biology.

[10]  H. Stanley,et al.  Molecular dynamics simulation of amyloid beta dimer formation. , 2004, Biophysical journal.

[11]  M. J. Ruiz-Montero,et al.  Numerical evidence for bcc ordering at the surface of a critical fcc nucleus. , 1995, Physical review letters.

[12]  A. Esteras-Chopo,et al.  Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. , 2007, Journal of molecular biology.

[13]  G. Bitan,et al.  Amyloid (cid:1) -Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS* , 2001 .

[14]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[15]  Amedeo Caflisch,et al.  Interpreting the aggregation kinetics of amyloid peptides. , 2006, Journal of molecular biology.

[16]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[17]  Anders Irbäck,et al.  PROFASI: A Monte Carlo simulation package for protein folding and aggregation , 2006, J. Comput. Chem..

[18]  P. Lansbury,et al.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.

[19]  G. J. Raymond,et al.  The most infectious prion protein particles , 2005, Nature.

[20]  S. Decatur,et al.  Experimental Evidence for the Reorganization of β-Strands within Aggregates of the Aβ(16−22) Peptide , 2005 .

[21]  H. Stanley,et al.  Molecular Dynamics Simulation of Amyloid β Dimer Formation , 2004, physics/0403040.

[22]  C. Hall,et al.  Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D Thirumalai,et al.  Monomer adds to preformed structured oligomers of Aβ-peptides by a two-stage dock–lock mechanism , 2007, Proceedings of the National Academy of Sciences.

[24]  M. Rowan,et al.  Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. , 2002, Biochemical Society transactions.

[25]  H. Aoyagi,et al.  Oligomerization process of the hemolytic lectin CEL-III purified from a sea cucumber, Cucumaria echinata. , 2002, Journal of biochemistry.

[26]  C. Finch,et al.  Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Thirumalai,et al.  Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.

[28]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[29]  Peter T. Lansbury,et al.  Observation of metastable Aβ amyloid protofibrils by atomic force microscopy , 1997 .

[30]  C. Dobson,et al.  Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. , 2005, Biophysical journal.

[31]  R. Leapman,et al.  Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. , 2000, Biochemistry.

[32]  G. Favrin,et al.  Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces. , 2004, Biophysical journal.

[33]  P. Lansbury,et al.  Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? , 2006, Quarterly Reviews of Biophysics.

[34]  J R Ghilardi,et al.  Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. , 2000, Biochemistry.

[35]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[36]  C. Dobson.  Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[37]  S. Decatur,et al.  Experimental evidence for the reorganization of beta-strands within aggregates of the Abeta(16-22) peptide. , 2005, Journal of the American Chemical Society.

[38]  G. Favrin,et al.  Monte Carlo update for chain molecules: Biased Gaussian steps in torsional space , 2001, cond-mat/0103580.

[39]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[40]  E. Bardaji,et al.  Inhibition of Plant-Pathogenic Bacteria by Short Synthetic Cecropin A-Melittin Hybrid Peptides , 2006, Applied and Environmental Microbiology.

[41]  Gerhard Hummer,et al.  Molecular dynamics simulations of Alzheimer's β-amyloid protofilaments , 2005 .

[42]  H. Huang,et al.  The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Aβ peptides , 2007, FEBS letters.

[43]  C. Dobson,et al.  Reversal of protein aggregation provides evidence for multiple aggregated States. , 2005, Journal of molecular biology.

[44]  C. Dobson.  Protein folding and misfolding , 2003, Nature.

[45]  D. Selkoe.  Folding proteins in fatal ways , 2003, Nature.

[46]  Feng Ding,et al.  Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases , 2005, PLoS Comput. Biol..

[47]  K. Hahm,et al.  Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures. , 2000, Biochemistry.

[48]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  G. Melacini,et al.  Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. , 2007, Journal of the American Chemical Society.

[50]  L. Mucke,et al.  100 Years and Counting: Prospects for Defeating Alzheimer's Disease , 2006, Science.

[51]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[52]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[53]  H. Stanley,et al.  Elucidating Amyloid β-Protein Folding and Assembly: A Multidisciplinary Approach , 2006 .

[54]  G. Boucher,et al.  Aggregating the amyloid Aβ11–25 peptide into a four‐stranded β‐sheet structure , 2006 .

[55]  Daan Frenkel,et al.  Quantitative prediction of crystal-nucleation rates for spherical colloids: a computational approach. , 2004, Annual review of physical chemistry.

[56]  S. Santini,et al.  In silico assembly of Alzheimer's Abeta16-22 peptide into beta-sheets. , 2004, Journal of the American Chemical Society.

[57]  D. Thirumalai,et al.  Dissecting the assembly of A β 16-22 amyloid peptides into antiparallel β-sheets , 2002 .

[58]  Fabrizio Chiti,et al.  Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity* , 2004, Journal of Biological Chemistry.

[59]  L. Lue,et al.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.

[60]  S. Lindquist,et al.  Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.

[61]  Anders Irbäck,et al.  Folding thermodynamics of three β‐sheet peptides: A model study , 2003, Proteins.

[62]  D. Thirumalai,et al.  Dissecting the assembly of Abeta16-22 amyloid peptides into antiparallel beta sheets. , 2003, Structure.

[63]  Christopher M. Dobson,et al.  Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms , 2006, The Journal of Neuroscience.

[64]  L. Serrano,et al.  Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations. , 2005, Journal of molecular biology.

[65]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[66]  Stefan Wallin,et al.  Thermodynamics of alpha- and beta-structure formation in proteins. , 2003, Biophysical journal.

[67]  Flavio Seno,et al.  Common attributes of native-state structures of proteins, disordered proteins, and amyloid. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[68]  M. Emmerling,et al.  Morphology and Toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[69]  A. Irbäck,et al.  Folding thermodynamics of peptides. , 2004, Biophysical journal.

[70]  Michael J. Rowan,et al.  Amyloid-β oligomers: their production, toxicity and therapeutic inhibition , 2001 .

[71]  Yoshihiro Kino,et al.  Comparative analysis of the cytotoxicity of homopolymeric amino acids. , 2005, Biochimica et biophysica acta.

[72]  Ruth Nussinov,et al.  Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. , 2006, Current opinion in chemical biology.

[73]  Gerhard Hummer,et al.  Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments. , 2005, Journal of molecular biology.

[74]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[75]  Elucidating amyloid beta-protein folding and assembly: A multidisciplinary approach. , 2006, Accounts of chemical research.